(Photo credit: Shutterstock.com)
By: Abigail Klein Leichman - Januray 6, 2021
Changing the gut microbiome can reprogram the immune system to attack malignant tumors, according to results of a unique clinical trial at Sheba Medical Center in Israel.
The results were published in the peer-reviewed journal Science by a research team led by senior GI oncologist Dr. Ben Boursi, senior oncologist Dr. Gal Markel and MD-PhD student Erez Baruch.
“For the first time in the world, we have successfully fought cancerous tumors by changing the gut microbiome,” Boursi said.
“Currently, immunotherapy works for only 40 percent to 50 percent of patients. We anticipate that with the help of this revolutionary treatment, we will see as many patients as possible transforming from non-responders to responders,” he said.
Read More: Israel21c